Lv547
1240 积分 2023-04-19 加入
GFH018 and toripalimab combination therapy for previously treated recurrent or metastatic nasopharyngeal carcinoma: Results from a phase 1b/2 study
1个月前
已完结
Capecitabine as salvage treatment in relapsed nasopharyngeal carcinoma: a phase II study
2年前
已关闭
Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial
2年前
已完结
Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial
2年前
已完结
Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: The JUPITER-02 Randomized Clinical Trial
1个月前
已采纳
The opium poppy genome and morphinan production
1个月前
已采纳
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
1个月前
已采纳
Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: The JUPITER-02 Randomized Clinical Trial
1个月前
已驳回
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR-Mutated Advanced NSCLC
1个月前
已采纳
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
1个月前
已采纳
ARL8B mediates lipid droplet contact and delivery to lysosomes for lipid remobilization
1个月前
已采纳
Long-Term Cognitive Safety of Achieving Very Low LDL Cholesterol with Evolocumab
1个月前
已采纳
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
1个月前
已采纳
皖公网安备34019202002308
